Cases
Representative Matters: Private Equity
Securities: Represented private equity firm Camden Partners in the $750 million sale of its portfolio company Ranir Global Holdings, the world's largest private label oral care company, to Perrigo Company PLC (NYSE, TASE: PRGO), a manufacturer of over-the-counter pharmaceuticals.
Represented a large multinational institutional investor as lead investor in connection with an $80 million preferred equity investment in a property management software company.
Represented a single-family office as lead investor in connection with a $23 million preferred equity investment in an immunotherapy biotechnology company.
Advised a middle market private equity fund in connection with the sale of its portfolio company, an international payment
transaction processing services business, for approximately $257 million.
Represented an SEC-registered alternative asset manager in the private credit space in connection with the negotiation
implementation of a $75 million construction equipment finance program platform.
Represented a multimedia entertainment company in connection with its recapitalization
issuance of $300 million of preferred stock to a private equity firm.
Advised a publicly traded investment fund as lead investor in a $115 million private placement of preferred stock by a transportation company.
Represented a private equity fund in connection with a series of preferred equity investments in a financial technology company totaling nearly $50 million.
Represented a private equity fund in connection with the sale of its interests in a healthcare technology portfolio company to affiliates of Kleiner Perkins for more than $35 million.
Advised an SEC-registered special situations investment fund in connection with a $46 million joint venture investment in a power generation facility.
Advised a leading global institutional investor in connection with its investment as lead investor in a $100 million private investment in public equity (PIPE) transaction.
Represented a biotechnology company in connection with its spinout from its corporate parent, issuance of preferred equity securities
subsequent acquisition
license of intellectual property assets relating to its business from MIT.
Represented a cybersecurity company in connection with its corporate restructuring
recapitalization
subsequent issuance of multiple tranches of preferred equity securities.
Advised a healthcare technology company in connection with its $110 million IPO.
Mergers & Acquisitions: Represented a leading natural personal care company in its cross-border sale to Australian conglomerate for total transaction value of more than $95 million
Subsequently advised the seller's management team in connection with the treatment of rollover equity upon the acquisition of the buyer by Bain Capital.
Represented a Fortune Global 100 chemical company in connection with its multimillion-dollar cross-border acquisition of a nanomaterials company.
Advised a digital marketing company in connection with its corporate reorganization
multimillion-dollar recapitalization by ORIX Corporate Capital, multiple roll-up acquisitions
subsequent sale to Baird Capital.
Advised a closely held B2B assessment
training services company in connection with its sale to a leading environment, health
safety solutions company owned by CVC Growth Partners.
Represented the lead institutional investor in a publicly traded special purpose acquisition company (SPAC) in connection with the SPAC's merger
the surviving company's subsequent listing on the NASDAQ stock exchange at an enterprise value of approximately $850 million.
Advised an education software company in connection with its sale to News Corp. for $360 million.
Represented an independent private equity sponsor in connection with a platform company acquisition in the government services industry, subsequent tuck-in acquisitions
related equity
debt financing transactions in support of the acquisitions.
Represented an e-commerce company in connection with the sale of its intellectual property portfolio to Google, Inc.
Represented a special committee of the board of directors of a financial institution with respect to its fiduciary duties to stockholders in connection with a proposed sale of the bank holding company.
Advised investors
management in connection with the formation of a financial services software company, its venture financing
its acquisition of intellectual property
other assets from a bankrupt entity through a Section 363 sale process.
Advised a NASDAQ-listed telemedicine company
its board of directors
management in connection with its sale to a multinational healthcare products
services company for $428 million.
Represented a consumer electronics manufacturer in connection with its sale to a publicly traded consumer products company for $136 million.
Debt Financings: Represented a telecommunications services company in connection with a senior secured syndicated ABL credit facility consisting of revolving
term loans from several large international banks
a subordinated term loan from private investors.
Advised one of the nation's leading banks in connection with multiple syndicated lending transactions to large corporate borrowers.
Represented an SBIC mezzanine-lending fund in connection with its investment in a manufacturing company through subordinated debt
equity securities.
Represented a mezzanine-lending fund in connection with its debt
equity investment in a business services company.
Represented a leading national bank in connection with numerous commercial
industrial loans.
